Google News – Clinical Trials External News
Life Sciences & Pharma Articles
Google News – Clinical Trials External News
From Potential to Practical at DIA 2026: Structure Before AI - Contract Pharma
Google News – Clinical Trials External News
Blue Earth Therapeutics announces first participant dosed in Phase 1 clinical trial investigating Actinium (²²⁵Ac) rhPSMA-10.1 Injection in metastatic castration-resistant prostate cancer - Morningstar
Google News – Clinical Trials External News
Sarcoidosis: A Clinical Trials Perspective - springermedicine.com
Google News – Clinical Trials External News
Quoin Pharmaceuticals Receives FDA IND Clearance to Initiate Phase 2 Study of QRX003 in Peeling Skin Syndrome - GlobeNewswire
Google News – Clinical Trials External News
Fate Therapeutics Receives FDA Clearance of Investigational New Drug Application for FT839 Product Candidate - GlobeNewswire
Google News – Clinical Trials External News
Eli Lilly’s Ebglyss wins Canadian drug approval for eczema - eciks.org
Google News – Pharmaceuticals External News
Ionis Pharmaceuticals (IONS) Faces Significant Pre-Market Decline of 18.9% - GuruFocus
Google News – Pharmaceuticals External News
Lynk Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Trial of LNK01004 Ointment for Vitiligo - Macau Business
Google News – Pharmaceuticals External News
60 Degrees Pharmaceuticals Announces Exclusive Option Agreement with Florida State University to Advance Castanospermine for Tick-Borne Diseases - Yahoo Finance
Google News – Pharmaceuticals External News
Ionis Pharmaceuticals (IONS) Phase 3 eplontersen trial in ATTR-CM fails primary goal - Stock Titan
Google News – Pharmaceuticals External News
Kiniksa Pharmaceuticals International (KNSA) Joins Russell Indexes, Is The Stock Fully Valued? - simplywall.st
Google News – Pharmaceuticals External News
Vanguard Health Care vs. VanEck Pharmaceutical: How Do These ETFs Stack Up? - The Motley Fool
Google News – Pharmaceuticals External News
Solaris Energy replaces Catalyst Pharmaceuticals in S&P SmallCap 600 as acquisition nears completion - Pluang
Google News – Pharmaceuticals External News